The Evidence Base for Diabetes Care

Now in its second edition, The Evidence Base for Diabetes Care has been fully revised and updated to incorporate new evidence from clinical trials. The aim of the book remains the same – to provide treatment recommendations based on the latest research and ensure patients with diabetes receive the best possible care.

Designed to be user-friendly, the evidence is displayed in clear tables with accompanying critiques including grading of evidence where appropriate. As well as summarizing the current evidence available for diabetes prevention and care, the contributors highlight areas where evidence is lacking and where studies are underway.

This book is an invaluable source of evidence-based information distilled into guidance for clinical practice.

William Herman

Professor Herman is an internationally recognized researcher, educator, and clinician in the prevention and treatment of diabetes. He is currently the Director of the Michigan Diabetes Research and Training Center. He has given over 125 invited lectures around the world, and has published eight books, 26 book chapters and almost 150 articles in peer-reviewed journals. He   was associate editor for the journals Clinical Diabetes and Diabetes Care.

Professor Herman is the recipient of the American Diabetes Association’s Kelly West Award for Outstanding Achievement in Epidemiology.

Rhys Williams

Professor Rhys Williams is Professor of Clinical Epidemiology at the University of Wales, Swansea. He is Vice-President of the International Diabetes Federation (IDF) and Chair of the IDF Task Force on Diabetes Awareness. He is also Chair of Diabetes UK’s Wales Advisory Council. His main research interests relate to diabetes and the metabolic syndrome, especially their epidemiology, health services research and economics.

Ann Louise Kinmonth

Professor Kinmonth is the Foundation Professor of General Practice at the University of Cambridge.

She has contributed through research to the management of diabetes and prevention of cardiovascular disease in general practice and is also interested   in the impact of genetics on general medical practice.

Nick Wareham

Professor Wareham is an Honorary Consultant at Addenbrooke’s Hospital, Cambridge.

He is Director of the MRC Epidemiology Unit and co-Director of the Institute of Metabolic Science. His principal research interests are the aetiology and prevention of obesity and diabetes. He also leads the Aetiology of Diabetes Programme and is the Clinical Lead for the Eastern England Diabetes Local Research Network.